Sign up to save your podcasts
Or
Share Neurotrophic Keratitis: Evolving Staging System and Emerging Agents
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Neurotrophic Keratitis: Evolving Staging System and Emerging Agents
CME credits: 1.00
Valid until: 20-12-2024
Claim your CME credit at https://reachmd.com/programs/cme/hiding-in-plain-sight-a--effort-to-improve-identification-and-treatment-of-thyroid-eye-disease/16477/
Management of neurotrophic keratitis (NK) is based on disease severity. During this webinar, the faculty members discuss updated viewpoints on what truly constitutes stage 1 disease as well as NK diagnostic strategies, treatment of stage 1 NK to prevent progression, and novel therapies.
This content was captured during a synchronous virtual symposium. Polling took place during the symposium.
=
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 1.00
Valid until: 20-12-2024
Claim your CME credit at https://reachmd.com/programs/cme/hiding-in-plain-sight-a--effort-to-improve-identification-and-treatment-of-thyroid-eye-disease/16477/
Management of neurotrophic keratitis (NK) is based on disease severity. During this webinar, the faculty members discuss updated viewpoints on what truly constitutes stage 1 disease as well as NK diagnostic strategies, treatment of stage 1 NK to prevent progression, and novel therapies.
This content was captured during a synchronous virtual symposium. Polling took place during the symposium.
=